Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weixue Huang

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
European Journal of Medicinal Chemistry|November 24, 2023
Discovery and optimization of thieno[3,2-d]pyrimidine derivatives as highly selective inhibitors of cyclin-dependent kinase 7Hongjin Zhang, Guohao Lin, Suyun Jia, et al.
Bioorganic Chemistry|May 18, 2024
Design, synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel potent CDK7 inhibitorsHongjin Zhang, Guohao Lin, Suyun Jia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 30, 2026
2<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitorsPinglian Wu, Zhaodi Tian, Weizhong Shen, et al.
European Journal of Medicinal Chemistry|November 26, 2023
Discovery of LWY713 as a potent and selective FLT3 PROTAC degrader with in vivo activity against acute myeloid leukemiaWenyan Liu, Yu Bai, Licheng Zhou, et al.
JACS Au|December 30, 2024
Structure-Based Design of "Head-to-Tail" Macrocyclic PROTACsChungen Li, Yihan Chen, Weixue Huang, et al.
European Journal of Medicinal Chemistry|July 31, 2025
The design and synthesis of selective and potent selenium-containing KRAS<sup>G12D</sup> inhibitorsLiping Zhou, Yayuan Yang, Bingzhong Chen, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinomaWeixue Huang, Liya Ding, Qiang Huang, et al.
Journal of Nanobiotechnology|January 31, 2026
Design of RGD-functionalized GSH-responsive pegylated polymeric protacs for selective BRD4 degradation and EndMT-driven cardiac fibrosis inhibitionTao Bi, Lei Chen, Ting Wang, et al.
Journal of Medicinal Chemistry|August 22, 2023
Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyveChungen Li, Yuanyuan Qiao, Xia Jiang, et al.
Journal of Medicinal Chemistry|January 25, 2023
Discovery of AXL Degraders with Improved Potencies in Triple-Negative Breast Cancer (TNBC) CellsRui He, Zhiqiang Song, Yu Bai, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
European Journal of Medicinal Chemistry|November 24, 2023
Discovery and optimization of thieno[3,2-d]pyrimidine derivatives as highly selective inhibitors of cyclin-dependent kinase 7Hongjin Zhang, Guohao Lin, Suyun Jia, et al.
Bioorganic Chemistry|May 18, 2024
Design, synthesis and evaluation of thieno[3,2-d]pyrimidine derivatives as novel potent CDK7 inhibitorsHongjin Zhang, Guohao Lin, Suyun Jia, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|March 30, 2026
2<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-amine derivatives as novel selective fibroblast growth factor receptor 2 (FGFR2) inhibitorsPinglian Wu, Zhaodi Tian, Weizhong Shen, et al.
European Journal of Medicinal Chemistry|November 26, 2023
Discovery of LWY713 as a potent and selective FLT3 PROTAC degrader with in vivo activity against acute myeloid leukemiaWenyan Liu, Yu Bai, Licheng Zhou, et al.
JACS Au|December 30, 2024
Structure-Based Design of "Head-to-Tail" Macrocyclic PROTACsChungen Li, Yihan Chen, Weixue Huang, et al.
European Journal of Medicinal Chemistry|July 31, 2025
The design and synthesis of selective and potent selenium-containing KRAS<sup>G12D</sup> inhibitorsLiping Zhou, Yayuan Yang, Bingzhong Chen, et al.
Hepatology (Baltimore, Md.)|August 5, 2010
Carbonyl reductase 1 as a novel target of (-)-epigallocatechin gallate against hepatocellular carcinomaWeixue Huang, Liya Ding, Qiang Huang, et al.
Journal of Nanobiotechnology|January 31, 2026
Design of RGD-functionalized GSH-responsive pegylated polymeric protacs for selective BRD4 degradation and EndMT-driven cardiac fibrosis inhibitionTao Bi, Lei Chen, Ting Wang, et al.
Journal of Medicinal Chemistry|August 22, 2023
Discovery of a First-in-Class Degrader for the Lipid Kinase PIKfyveChungen Li, Yuanyuan Qiao, Xia Jiang, et al.
Journal of Medicinal Chemistry|January 25, 2023
Discovery of AXL Degraders with Improved Potencies in Triple-Negative Breast Cancer (TNBC) CellsRui He, Zhiqiang Song, Yu Bai, et al.
Pageof 4